2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1.9B | $1.9B | $1.8B | $1.9B | $2B |
Cost of Revenue | $1.4B | $1.3B | $1.4B | $1.6B | $1.5B |
Gross Profit | $499M | $526M | $432M | $307M | $468M |
Gross Profit % | 26% | 28% | 23% | 16% | 24% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $55M | -$52M | $122M | $68M | $69M |
Dep. & Amort. | $151M | $135M | $128M | $127M | $128M |
Def. Tax | $4.9M | $99M | $11M | -$2.7M | -$7.7M |
Stock Comp. | $17M | $19M | $18M | $21M | $26M |
Chg. in WC | $34M | $21M | -$59M | $8.4M | $26M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $113M | $300M | $149M | $122M | $107M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $113M | $300M | $149M | $122M | $107M |
Receivables | $268M | $283M | $312M | $312M | $289M |
Inventory | $303M | $18M | $20M | $1 | $0 |
CoreCivic anticipates significant growth opportunities, particularly with federal partners like ICE and the U.S. Marshals Service, driven by new policies and legislative changes under the current administration.
The company has submitted a proposal to ICE for 28,000 beds, which could generate up to $750-$800 million in revenue and $200-$275 million in incremental EBITDA if fully activated.
CoreCivic is proactively preparing for potential facility activations, including $40-$45 million in capital expenditures for facility readiness and transportation assets, with startup costs estimated at $4,000-$6,000 per bed.
2025 financial guidance includes diluted EPS of $0.48-$0.61 and FFO per share of $1.37-$1.50, with potential upside from new contracts not yet included in the forecast.
The company is exploring opportunities for state contracts, federal partnerships, and potential acquisitions while maintaining a disciplined approach to leverage and capital allocation.